FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
CODEINE SULFATE
codeine sulfate
LOE Approaching
Hikma
ORAL · TABLET
mild to moderate painwhere treatment with an opioid is appropriate+1
2009
NDA30/100
CODEPREX
chlorpheniramine polistirex; codeine polistirex
LOE Approaching
ORAL · SUSPENSION, EXTENDED RELEASE
2004
NDA30/100
COGENTIN
benztropine mesylate
LOE Approaching
Merck & Co.
ORAL · TABLET
of extrapyramidal disorders (except tardive dyskinesia – see ) due to neuroleptic drugs (e
1954
NDA30/100
COGENTIN
benztropine mesylate
LOE Approaching
INJECTION · INJECTABLE
of extrapyramidal disorders (except tardive dyskinesia – see ) due to neuroleptic drugs (e
1959
NDA30/100
COGNEX
tacrine hydrochloride
LOE Approaching
Shionogi
ORAL · CAPSULE
1993
NDA30/100
COLBENEMID
colchicine; probenecid
LOE Approaching
Merck & Co.
ORAL · TABLET
gout flaresacute gout flares+2
1961
NDA30/100
COLCRYS
colchicine
LOE Approaching
Molecular Devices
ORAL · TABLET
gout flaresacute gout flares+2
2009
NDA30/100
COLCRYS
colchicine
LOE Approaching
Molecular Devices
ORAL · TABLET
gout flaresacute gout flares+2
2009
NDA30/100
COLD CAPSULE IV
chlorpheniramine maleate; phenylpropanolamine hydrochloride
LOE Approaching
ORAL · CAPSULE, EXTENDED RELEASE
these symptoms due to hay feverother upper respiratory allergies: runny nose itchy+2
1985
NDA30/100
COLD CAPSULE V
chlorpheniramine maleate; phenylpropanolamine hydrochloride
LOE Approaching
ORAL · CAPSULE, EXTENDED RELEASE
these symptoms due to hay feverother upper respiratory allergies: runny nose itchy+2
1985
NDA30/100
COLESTID
colestipol hydrochloride
LOE Approaching
Pfizer
ORAL · TABLET
hypertension
1994
NDA30/100
COLESTID
colestipol hydrochloride
LOE Approaching
Pfizer
ORAL · GRANULE
hypertension
1977
NDA30/100
COLGATE TOTAL
sodium fluoride; triclosan
LOE Approaching
DENTAL · PASTE
reduce plaquegingivitis helps control plaque bacteria+2
1997
NDA30/100
COLPREP KIT
magnesium sulfate; potassium sulfate; sodium sulfate
Peak
R-Pharm US
ORAL · POWDER
2016
NDA30/100
COLY-MYCIN M
colistimethate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
acutechronic infections due to sensitive strains of certain gram-negative bacilli
1970
NDA30/100
COLY-MYCIN S
colistin sulfate, neomycin sulfate, thonzonium bromide and hydrocortisone acetate
LOE Approaching
Pfizer
OTIC · SUSPENSION/DROPS
superficial bacterial infections of the external auditory canalcaused by organisms susceptible to the action of the antibiotics
1962
NDA30/100
COLYTE
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
LOE Approaching
ORAL · FOR SOLUTION
1984
NDA30/100
COLYTE WITH FLAVOR PACKS
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
LOE Approaching
ORAL · FOR SOLUTION
1984
NDA30/100
COLYTE-FLAVORED
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
LOE Approaching
ORAL · FOR SOLUTION
1984
NDA30/100
COMBIGAN
brimonidine tartrate, timolol maleate
LOE Approaching
AbbVie
OPHTHALMIC · SOLUTION/DROPS
elevated intraocular pressure (IOP) in patients with glaucomaocular hypertension+3
2007
NDA30/100
COMBIPATCH
estradiol/norethindrone acetate transdermal system
LOE Approaching
Noven Pharmaceuticals
TRANSDERMAL · FILM, EXTENDED RELEASE
a woman with a uterus for: Treatment of moderate to severe vasomotor symptoms due to menopause
1998
NDA30/100
COMBIPRES
chlorthalidone; clonidine hydrochloride
LOE Approaching
Boehringer Ingelheim
ORAL · TABLET
the management of hypertension eitherto enhance the effect of other antihypertensive drugs in the more severe forms of hypertension+7
1974
NDA30/100
COMBIVENT
albuterol sulfate; ipratropium bromide
LOE Approaching
Boehringer Ingelheim
INHALATION · AEROSOL, METERED
chronic obstructive pulmonary diseaseCOPD
1996
NDA30/100
COMBIVIR
lamivudine and zidovudine
LOE Approaching
GSK
ORAL · TABLET
combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV‑1) infectioncombination with other antiretroviral agents for the treatment of HIV‑1 infection
1997
NDA30/100